Ghrelin, a 28-amino acid hormone produced mainly by the X/A-like endocrine cells in gastric mucosa, has a widespread tissue distribution and diverse physiological functions such as hormonal, orexigenic, metabolic, cardiovascular, neurological, and immunological activities. Considerable evidence has suggested that ghrelin plays an important role in organism senescence or aging. The present review provides a comprehensive picture of this new development. We first reviewed the aging (senescence)-dependent reduction of ghrelin signaling, and then highlighted its relationship with the aging-associated alteration in food intake, energy metabolism, cardiovascular function, neurological activity, and adaptive immunity. Our literature review suggests that ghrelin is an innovative and promising agent in the treatment of these pathophysiological conditions associated with senescence.

Keywords:
Glucose homeostasis, Lipid metabolism, Cardiovascular function, Aging, Growth hormone secretagogue receptor, Neurodegeneration, Food intake
1.
Kojima M, Hosoda H, Date Y, et al: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
2.
Liu YL, Yakar S, Otero-Corchon V, et al: Ghrelin gene expression is age-dependent and influenced by gender and the level of circulating IGF-I. Mol Cell Endocrinol 2002;189:97-103.
3.
Kappeler L, Zizzari P, Alliot J, et al: Delayed age-associated decrease in growth hormone pulsatile secretion and increased orexigenic peptide expression in the Lou C/JaLL rat. Neuroendocrinology 2004;80:273-283.
4.
Akimoto Y, Kanai S, Ohta M, et al: Age-associated reduction of stimulatory effect of ghrelin on food intake in mice. Arch Gerontol Geriatr 2012;55:238-243.
5.
Sun Y, Garcia JM, Smith RG: Ghrelin and growth hormone secretagogue receptor expression in mice during aging. Endocrinology 2007;148:1323-1329.
6.
Wolden-Hanson T: Mechanisms of the anorexia of aging in the Brown Norway rat. Physiol Behav 2006;88:267-276.
7.
Sturm K, MacIntosh CG, Parker BA, et al: Appetite, food intake, and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women. J Clin Endocrinol Metab 2003;88:3747-3755.
8.
Rigamonti AE, Pincelli AI, Corra B, et al: Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J Endocrinol 2002;175:R1-R5.
9.
Nass R, Farhy LS, Liu J, et al: Age-dependent decline in acyl-ghrelin concentrations and reduced association of acyl-ghrelin and growth hormone in healthy older adults. J Clin Endocrinol Metab 2014;99:602-608.
10.
Schneider SM, Al-Jaouni R, Caruba C, et al: Effects of age, malnutrition and refeeding on the expression and secretion of ghrelin. Clin Nutr 2008;27:724-731.
11.
Katayama M, Nogami H, Nishiyama J, et al: Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland. Neuroendocrinology 2000;72:333-340.
12.
Wu R, Zhou M, Dong W, et al: Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock. Ann Surg 2009;250:126-133.
13.
Ang GL, Shi X, Salisbury E, et al: Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex. J Biol Chem 2007;282:1468-1478.
14.
Jiang H, Betancourt L, Smith RG: Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 2006;20:1772-1785.
15.
Sun Y, Asnicar M, Saha PK, et al: Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006;3:379-386.
16.
Andrews ZB, Horvath B, Barnstable CJ, et al: Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J Neurosci 2005;25:184-191.
17.
Lin L, Nuotio-Antar AM, Ma X, et al: Ghrelin receptor regulates appetite and satiety during aging in mice by regulating meal frequency and portion size but not total food intake. J Nutr 2014;144:1349-1355.
18.
Lin L, Saha PK, Ma X, et al: Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011;10:996-1010.
19.
Lin L, Lee JH, Bongmba OY, et al: The suppression of ghrelin signaling mitigates age-associated thermogenic impairment. Aging 2014;6:1019-1032.
20.
Iwakura H, Hosoda K, Son C, et al: Analysis of rat insulin II promoter-ghrelin transgenic mice and rat glucagon promoter-ghrelin transgenic mice. J Biol Chem 2005;280:15247-15256.
21.
Reed JA, Benoit SC, Pfluger PT, et al: Mice with chronically increased circulating ghrelin develop age-related glucose intolerance. Am J Physiol Endocrinol Metab 2008;294:E752-E760.
22.
Ariyasu H, Iwakura H, Yamada G, et al: Efficacy of ghrelin as a therapeutic approach for age-related physiological changes. Endocrinology 2008;149:3722-3728.
23.
Ma X, Lin L, Qin G, et al: Ablations of ghrelin and ghrelin receptor exhibit differential metabolic phenotypes and thermogenic capacity during aging. PLoS One 2011;6:e16391.
24.
Nesic DM, Stevanovic DM, Stankovic SD, et al: Age-dependent modulation of central ghrelin effects on food intake and lipid metabolism in rats. Eur J Pharmacol 2013;710:85-91.
25.
Choi K, Roh SG, Hong YH, et al: The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 2003;144:754-759.
26.
Li Z, Xu G, Qin Y, et al: Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARgamma signaling pathway. Proc Natl Acad Sci USA 2014;111:13163-13168.
27.
van der Velde M, van der Eerden BC, Sun Y, et al: An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 2012;153:3593-3602.
28.
Jurimae J, Kums T, Jurimae T: Adipocytokine and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations. Eur J Endocrinol 2009;160:381-385.
29.
Weiss LA, Langenberg C, Barrett-Connor E: Ghrelin and bone: is there an association in older adults?: the Rancho Bernardo study. J Bone Miner Res 2006;21:752-757.
30.
Isgaard J, Granata R: Ghrelin in cardiovascular disease and atherogenesis. Mol Cell Endocrinol 2011;340:59-64.
31.
Li A, Cheng G, Zhu GH, et al: Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem Biophys Res Commun 2007;353:238-243.
32.
Beaumont NJ, Skinner VO, Tan TM, et al: Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem 2003;278:8877-8880.
33.
De Vriese C, Hacquebard M, Gregoire F, et al: Ghrelin interacts with human plasma lipoproteins. Endocrinology 2007;148:2355-2362.
34.
Dos Santos VV, Rodrigues AL, De Lima TC, et al: Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease. Curr Pharm Des 2013;19:6773-6790.
35.
Stoyanova II: Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiol Dis 2014;72:72-83.
36.
Kern A, Albarran-Zeckler R, Walsh HE, et al: Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 2012;73:317-332.
37.
Andrews ZB, Erion D, Beiler R, et al: Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 2009;29:14057-14065.
38.
Lin MT, Beal MF: Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443:787-795.
39.
Marongiu R, Spencer B, Crews L, et al: Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem 2009;108:1561-1574.
40.
O'Neill HM, Maarbjerg SJ, Crane JD, et al: AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci USA 2011;108:16092-16097.
41.
Joo JH, Dorsey FC, Joshi A, et al: Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. Mol Cell 2011;43:572-585.
42.
Zhang W, Lin TR, Hu Y, et al: Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus. J Physiol 2004;559:729-737.
43.
Dixit VD, Yang H, Sun Y, et al: Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007;117:2778-2790.
44.
Youm YH, Yang H, Sun Y, et al: Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J Biol Chem 2009;284:7068-7077.
45.
Dixit VD, Yang H, Cooper-Jenkins A, et al: Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood 2009;113:5202-5205.
46.
Porporato PE, Filigheddu N, Reano S, et al: Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 2013;123:611-622.
47.
Sugiyama M, Yamaki A, Furuya M, et al: Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Regul Pept 2012;178:21-28.
48.
Sangiao-Alvarellos S, Vazquez MJ, Varela L, et al: Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology 2009;150:4562-4574.
49.
Taub DD, Murphy WJ, Longo DJ: Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Pharmacol 2010;10:408-424.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.